Align Technology (ALGN) Gets $250 Target as Invisalign Demand Shows Recovery Signs

Align Technology, Inc. (NASDAQ:ALGN) ranks among the best medical stocks to buy according to analysts. Piper Sandler reaffirmed its $250 price target and Overweight rating on Align Technology, Inc. (NASDAQ:ALGN) on July 23 ahead of the company’s second-quarter earnings report.

According to the firm, June clear aligner volumes rose 3.9% (roughly flat when accounting for an additional day), bringing the total volume for the quarter to -3.1%. These results are characterized as “unequivocally better” than those shown in the monthly orthodontic data year-to-date and relative to late 2024.

Piper Sandler was hopeful that this could be the start of a demand trend reversal, pointing to consistent volume increases in the adult and teen categories as well as favorable trending patient exam data as a leading indicator.

Align Technology, Inc. (NASDAQ:ALGN), recognized as a leader in 3D-printed dental treatments, is a prominent medical device company that employs 3D printing to manufacture Invisalign systems, which straighten teeth with removable and custom-made aligners.

While we acknowledge the potential of ALGN as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

Read More: 10 Best Magic Formula Stocks for 2025 and 10 Best Retirement Stocks to Buy According to Hedge Funds

Disclosure: None.